STOCK TITAN

Gabelli group (NYSE: GRX-related) reports 5.5M GRX preferred shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Gabelli-affiliated investors report a large stake in Gabelli Healthcare & WellnessRx Trust’s preferred shares. The reporting group discloses beneficial ownership of 5,500,000 preferred shares, representing 77.77% of the 7,072,014 preferred shares outstanding. Key holders include Associated Capital Group, Inc. with 2,400,000 shares (33.94%), Mario Gabelli with 1,200,000 shares (16.97%), Gabelli Foundation with 1,000,000 shares (14.14%), GAMCO Investors, Inc. with 500,000 shares (7.07%), GGCP, Inc. with 200,000 shares (2.83%), and GAMCO Asset Management Inc. and MJG Associates, Inc. with 100,000 shares each (1.41% each). The filing notes these positions were built in part through a private placement, with the reporting persons using an aggregate of approximately $23,860,000 to purchase additional Series E and Series G cumulative preferred shares on 12/26/2025.

Positive

  • None.

Negative

  • None.

Insights

Gabelli-related entities now control over three‑quarters of GRX preferreds.

The filing shows Gabelli-affiliated entities and individuals collectively beneficially own 5,500,000 preferred shares of Gabelli Healthcare & WellnessRx Trust, or 77.77% of the 7,072,014 preferred shares outstanding. The largest single holder is Associated Capital Group, Inc. with 2,400,000 shares (33.94%), followed by Mario Gabelli personally with 1,200,000 shares (16.97%) and Gabelli Foundation, Inc. with 1,000,000 shares (14.14%).

Item 3 explains that the reporting persons used an aggregate of about $23,860,000 to buy additional Series E and Series G cumulative preferred shares since the prior filing, in a private placement. Individual funding sources include roughly $12,000,000 of private funds from MJG, $4,860,000 of working capital from the Foundation, and $2,000,000 each from GGCP and AC. These purchases on 12/26/2025 at $10.0000 per share significantly increased their preferred stake.

The group states it is using the long-form Schedule 13D because it may regularly communicate with the issuer’s management, and wants those discussions to remain consistent with Exchange Act reporting obligations. This emphasizes an active, rather than purely passive, posture toward the preferred investment, though any future impact will depend on how these communications and governance dynamics evolve.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


GAMCO INVESTORS, INC. ET AL
Signature:PETER D. GOLDSTEIN
Name/Title:CHIEF LEGAL OFFICER
Date:12/29/2025
GAMCO Asset Management Inc.
Signature:DOUGLAS R. JAMIESON
Name/Title:PRESIDENT
Date:12/29/2025
GABELLI FOUNDATION, INC.
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:12/29/2025
MJG ASSOCIATES, INC.
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:12/29/2025
GGCP, INC.
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:12/29/2025
Associated Capital Group, Inc.
Signature:PETER D. GOLDSTEIN
Name/Title:CHIEF LEGAL OFFICER
Date:12/29/2025
GABELLI MARIO J
Signature:DAVID GOLDMAN
Name/Title:ATTORNEY-IN-FACT
Date:12/29/2025

FAQ

What stake do Gabelli-related investors report in Gabelli Healthcare & WellnessRx Trust (GRX) preferred shares?

The reporting group discloses beneficial ownership of 5,500,000 preferred shares of Gabelli Healthcare & WellnessRx Trust, representing 77.77% of the 7,072,014 preferred shares outstanding.

Which entities hold the largest portions of GRX preferred shares in this Schedule 13D/A?

Associated Capital Group, Inc. holds 2,400,000 preferred shares (33.94%), Mario Gabelli holds 1,200,000 shares (16.97%), and Gabelli Foundation, Inc. holds 1,000,000 shares (14.14%).

How much did the reporting persons spend to increase their GRX preferred holdings?

Item 3 states the reporting persons used an aggregate of approximately $23,860,000 to purchase additional Series E and Series G cumulative preferred shares in a private placement since the most recent filing.

What recent transactions in GRX preferred shares are disclosed in the filing?

On 12/26/2025, several reporting persons purchased Series E and Series G cumulative preferred shares at $10.0000 per share, including Gabelli Foundation (486,000 shares), Mario J. Gabelli (1,200,000), GGCP, Inc. (200,000), GAMCO Asset Management Inc. (110,000), MJG Associates, Inc. (100,000), Associated Capital Group, Inc. (200,000), and GAMCO Investors, Inc. (100,000).

Why are the reporting persons using the long-form Schedule 13D instead of Schedule 13G for GRX?

Item 4 explains that they file the long form Schedule 13D under Section 13d-1 of the Exchange Act because they may regularly communicate with the issuer’s management, and this filing format helps keep those conversations compliant with reporting obligations.

Who are the main reporting persons in this GRX Schedule 13D/A amendment?

The filing lists multiple Gabelli-affiliated entities and individuals, including GGCP, Inc., GAMCO Investors, Inc., Associated Capital Group, Inc., GAMCO Asset Management Inc., Gabelli Funds, LLC, MJG Associates, Inc., Gabelli Foundation, Inc., and Mario Gabelli, among others.

Gabelli Health & Wellness

NYSE:GRX

GRX Rankings

GRX Latest News

GRX Latest SEC Filings

GRX Stock Data

149.07M
15.50M
1.83%
37.13%
0.02%
Asset Management
Financial Services
Link
United States
Rye